
Originally Posted by
johnnymk
from Newsmax.com
Drug companies fund a growing number of the studies in leading psychiatric journals, and drugs fare much better in these company-funded studies than in trials done independently or by competitors, researchers reported.
According to a report in USA Today about 57 percent of published studies were paid for by drug companies in 2002, compared with 25 percent in 1992, says psychiatrist Igor Galynker of Beth Israel Medical Center in New York City.
There were favorable outcomes for a medication in about:
Eight out of 10 studies paid for by the company that makes the drug.
Five out of 10 studies done with no industry support.
Three out of 10 studies done by competitors of the firm making the drug.
The findings don't prove the companies are knowingly biasing studies, says co-author Robert Kelly Jr., also with Beth Israel. The report didn't look at the evidence for bias in design of the studies.
Bookmarks